Want to share your screen? See the person you're talking to? Contact us via digital library desk! We will be with you shortly.
Monday-Friday
The 2025 national quota for Open Access publishing at no cost to authors under the American Chemical Society (ACS) Read & Publish agreement has now been fully utilised. This means that for the remainder of 2025, no further articles can be published Open Access at no cost in ACS journals through our institutional agreement.
Any new manuscripts accepted by ACS in 2025 will not be eligible for fee-waived Open Access publication; instead, authors will either need to pay the article processing charges (APC) or publish their work under the traditional (closed access) model.
Even though the ACS quota is exhausted, researchers can still make their ACS publications openly accessible through Green Open Access. We strongly encourage authors to publish new ACS articles as closed access and then deposit the accepted manuscript in DORA, the institutional repository for Eawag, Empa, PSI, and WSL. Sharing the accepted version of your paper in DORA (after the standard ACS embargo period of 12 months) ensures your research is freely available to the public at no cost.
Negotiations for a new Open Access agreement with ACS starting in 2026 are ongoing, and we will share updates as they become available. The problematic restrictions of the current agreement (e.g. quota, exclusion of SNSF-funded works) should be removed, and we support the Swiss negotiation team in pursuing that outcome.
Do you want to know more about the background of national negotiations with scientific publishers? Don't miss the coffee lecture "No Deal - No problem? Strategies for Reaching Negotiation Goals with Scholarly Publishers" on 02 December, 13:30 - 14:00. Learn more about the event here.